Dysregulation of cellular signaling in gastric cancer

Cancer Lett. 2010 Sep 28;295(2):144-53. doi: 10.1016/j.canlet.2010.04.025. Epub 2010 May 21.

Abstract

The pathogenesis of gastric cancer is complex and related to multiple factors. Dysregulation of intracellular signaling pathways represents a common pathogenic mechanism and may be amenable to drug targeting. Multiple well-established oncogenic pathways, such as those mediated by cell cycle regulators, nuclear factor-kappaB, cyclooxygenase-2 and epidermal growth factor receptor are implicated in gastric carcinogenesis. Emerging evidence also underscores the importance of signaling pathways involved in the developmental process, including transforming growth factor-beta/bone morphogenetic protein signaling, Wnt/beta-catenin signaling, Hedgehog signaling and Notch signaling. Understanding their biological significance will provide a rational basis for drug development. Their relative importance and cross-talk in gastric carcinogenesis, however, are still not completely understood and warrant further investigation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cyclin-Dependent Kinase Inhibitor p21 / physiology
  • Cyclin-Dependent Kinase Inhibitor p27
  • Cyclins / physiology
  • Humans
  • Intracellular Signaling Peptides and Proteins / physiology
  • Leukotrienes / physiology
  • MAP Kinase Signaling System
  • NF-kappa B / physiology
  • Plasminogen Activators / physiology
  • Receptor, ErbB-2 / physiology
  • Receptors, Notch / physiology
  • Signal Transduction / physiology*
  • Stomach Neoplasms / metabolism*
  • Tumor Suppressor Protein p53 / physiology

Substances

  • CDKN1A protein, human
  • CDKN1B protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Intracellular Signaling Peptides and Proteins
  • Leukotrienes
  • NF-kappa B
  • Receptors, Notch
  • Tumor Suppressor Protein p53
  • Cyclin-Dependent Kinase Inhibitor p27
  • Receptor, ErbB-2
  • Plasminogen Activators